专利检索 ap:("SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION" OR "INDUSTRY-ACADEMIC COOPERATION FOUNDATION OF SUNCHON NATIONAL UNIVERSITY" OR "SEOUL NATIONAL UNIVERSITY HOSPITAL") AND inv:"Ae-Kyung Park" 第 1 页

1.

发明授权
Biomarker for measurement of response and prognosis of triple-negative breast cancer to anticancer agent 有权

公开(公告)号：US11339446B2

公开(公告)日：2022-05-24

申请号：US16494557

申请日：2018-03-08

申请人： SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION , INDUSTRY-ACADEMIC COOPERATION FOUNDATION OF SUNCHON NATIONAL UNIVERSITY , SEOUL NATIONAL UNIVERSITY HOSPITAL

发明人： Wonshik Han , Dong-Young Noh , Han-Byoel Lee , Eun-Kyu Kim , Ae-Kyung Park , Hyeong-Gon Moon

IPC分类号： C12Q1/6886

摘要： The present disclosure discloses a biomarker capable of predicting the therapeutic response to anticancer agents and prognosis of triple-negative breast cancer patients, and the use thereof. A biomarker according to the present disclosure allows the provision of optimized personal therapeutic methods through correct personalized treatment, contributing to the quality and prolongation of life of patients.